Disease Control in Cutaneous Leishmaniasis is Independent of IL-22

Journal of Investigative Dermatology

Volumn 135, Issue 1, 2015, Pages 308-311

  Brosch, Sven ^a   Dietze Schwonberg, Kirsten ^a   Lopez Kostka, Susanna ^a   Lorenz, Beate ^a   Haak, Stefan ^b,c   Becher, Burkhard ^b   Von Stebut, Esther ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b UNIVERSITY OF ZURICH   (Switzerland)

^c INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 22; INTERLEUKIN 4; CD4 ANTIGEN; CD8 ANTIGEN; INTERLEUKIN 12P40; INTERLEUKIN DERIVATIVE; INTERLEUKIN-22;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN SPECIFICITY; CD4+ T LYMPHOCYTE; CYTOKINE PRODUCTION; CYTOKINE RELEASE; CYTOKINE RESPONSE; DISEASE CONTROL; GAMMA DELTA T LYMPHOCYTE; IMMUNE RESPONSE; LEISHMANIA MAJOR; LETTER; MOUSE; NONHUMAN; PARASITE TRANSMISSION; PRIORITY JOURNAL; SKIN LEISHMANIASIS; TH17 CELL; ADAPTIVE IMMUNITY; CD8+ T LYMPHOCYTE; HUMAN; IMMUNOMODULATION; LEISHMANIA BRAZILIENSIS; NATURAL KILLER CELL; PARASITE CLEARANCE; PARASITE LOAD; PROMASTIGOTE; REGULATORY T LYMPHOCYTE; TH1 TH2 BALANCE; ANIMAL; BAGG ALBINO MOUSE; C57BL MOUSE; DISEASE MODEL; IMMUNOLOGY; PARASITOLOGY; PATHOLOGY;

ANIMALS; DISEASE MODELS, ANIMAL; INTERLEUKINS; LEISHMANIASIS, CUTANEOUS; MICE, INBRED BALB C; MICE, INBRED C57BL; TH17 CELLS;

EID: 84925231854     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2014.282     Document Type: Letter

References (16)

1. de Assis Souza M, de Castro MC, de Oliveira AP et al. (2013) Cytokines and NO in American tegumentary leishmaniasis patients: profiles in active disease, after therapy and in self-healed individuals. Microb Pathog 57:27-32
2. Belkaid Y, Mendez S, Lira R et al. (2000) A natural model of Leishmania major infection reveals a prolonged ''silent'' phase of parasite amplification in the skin before the onset of lesion formation and immunity. J Immunol 165:969-77
3. Gonzalez-Lombana C, Gimblet C, Bacellar O et al. (2013) IL-17 mediates immunopathology in the absence of IL-10 following Leishmania major infection. PLoS Pathog 9:e1003
4. Ghosh K, Sharma G, Saha A et al. (2013) Successful therapy of visceral leishmaniasis with curdlan involves T-helper 17 cytokines. J Infect Dis 207:1016-25
5. Hezarjaribi HZ, Ghaffarifar F, Dalimi A et al. (2013) Effect of IL-22 on DNA vaccine encoding LACK gene of Leishmania major in BALB/ c mice. Exp Parasitol 134:341-8
6. Kautz-Neu K, Noordegraaf M, Dinges S et al. (2011) Langerhans cells are negative regulators of the anti-Leishmania response. J Exp Med 208:885-91
7. Lopez Kostka S, Dinges S, Griewank K et al. (2009) IL-17 promotes progression of cutaneous leishmaniasis in susceptible mice. J Immunol 182:3039-46
8. Pitta MG, Romano A, Cabantous S et al. (2009) IL-17 and IL-22 are associated with protection against human kala azar caused by Leishmania donovani. J Clin Invest 119:2379-87
9. Rubino SJ, Geddes K, Girardin SE (2012) Innate IL-17 and IL-22 responses to enteric bacterial pathogens. Trends Immunol 33:112-8
10. Sacks D, Noben-Trauth N (2002) The immunology of susceptibility and resistance to Leishmania major in mice. Nat Rev Immunol 2:845-58
11. Sonnenberg GF, Fouser LA, Artis D (2010) Functional biology of the IL-22-IL-22R pathway in regulating immunity and inflammation at barrier surfaces. Adv Immunol 107:1-29
12. Wilson MS, Feng CG, Barber DL et al. (2010) Redundant and pathogenic roles for IL-22 in mycobacterial, protozoan, and helminth infections. J Immunol 184:4378-90
13. Wolk K, Warszawska K, Hoeflich C et al. (2011) Deficiency of IL-22 contributes to a chronic inflammatory disease: pathogenetic mechanisms in acne inversa. J Immunol 186:1228-39
14. Wolk K, Witte E, Witte K et al. (2010) Biology of interleukin-22. Semin Immunopathol 32: 7-31
15. Wö lbing F, Lopez Kostka S, Moelle K et al. (2006) Uptake of Leishmania major by dendritic cells is mediated by Fcg receptors and facilitates acquisition of protective immunity. J Exp Med 203:177-88
16. Zenewicz LA, Flavell RA (2011) Recent advances in IL-22 biology. Int Immunol 3:159-63